Liging, Nasri M.

HRN: 22-24-60  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2025
CEFUROXIME 750MG (VIAL)
08/11/2025
08/17/2025
IVT
300mg
Q8H
AGE With Moderate Dehydration; Pneumonia
Checking Initial Appropriateness 
08/12/2025
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
08/12/2025
08/14/2025
PO
5ml
BID
Ascariasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: